Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis

Published:2020-06 Issue: Volume:28 Page:100529
ISSN:2352-9067
Container-title:IJC Heart & Vasculature
language:en
Short-container-title:IJC Heart & Vasculature

Author:

Sato-Okabayashi Yayoi,Isoda Kikuo,Heissig Beate,Kadoguchi Tomoyasu,Akita Koji,Kitamura Kenichi,Shimada Kazunori,Hattori Koichi,Daida Hiroyuki

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Inflammation in atherosclerosis;Libby;Nature,2002

2. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice;Steffens;Nature,2005

3. Differential metabolic effects of distinct statins;Koh;Atherosclerosis.,2011

4. Immunomodulatory and anti-inflammatory activities of statins;Mira;Endocr. Metab. Immune Disord. Drug Targets.,2009

5. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy;Hartman;Cardiol. Rev.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corchorus olitorius L. increased NK cell and macrophage functions on the cyclophosphamide-induced immunosuppressed rat;Journal of Functional Foods;2024-08

2. TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus;Biologics: Targets and Therapy;2024-05

3. Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles;Environmental Research;2024-03

4. The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study;Diagnostics;2023-02-23

5. Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues;Frontiers in Cardiovascular Medicine;2022-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3